Clinical Trials for Plantar Fasciitis

Current Clinical Trials for Plantar Fasciitis

Here is the promised article about randomized double-blind clinical trials that relate to Plantar Fasciitis. This article will discuss the current ongoing clinical trials for plantar fasciitis and/or fasciosis. For some, this information will be better than gold. There will be information given for three test studies that are currently recruiting participants. The first one is the Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis, the second is Efficacy of the TOPAZ™ Microdebridement Procedure for Treating Plantar Fasciosis, and the third is Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports.

The purpose of the Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis, is to find out if one single injection of Dysport (200 MU) will result in a significant reduction in the symptoms of plantar fasciitis.

They will be accepting 40 participants. This study is open to both males and females over the age of 18. The criteria includes the requirement of diagnosed plantar fasciitis for at least four months or longer, at least two previous unsuccessful conservative therapies, and pain within the previous 48 hours.

Rheumatoid disease is cause for exclusion as well as previous surgery in the affected foot.

The following locations are conducting this scientific study:

  • University Hospital Charite, Musculoskeletal Centre, Berlin, Germany
  • Orthopedic Practice, Weiden,Germany
  • Orthopedic Practice, Karlsruhe, Germany
  • Orthocentre Munich, Munich, Germany
  • Orthopedic Practice Biberburg, Berlin, Germany

The Microdebridement Procedure for Treating Plantar Fasciosis is actually a post-surgery procedure for patients who have evidence of plantar fasciosis–degenerative process of the fascia.

Ninety healthy participants, male or female, between the ages of 18 and 65 will be accepted for inclusion in the study. Thickening of the plantar fascia is a requirement.

Candidates who have used NSAID’s such as Naprosyn or Ibuprofen during the previous two weeks, a history of diabetes types I and II, history of fibromyalgia, autoimmune disease, previous fascia surgery, or any infection, tumor, or pregnancy will be excluded.

Anyone interested in participitating in this study can contact one of the following clinics:

Arizona

  • Foot Care Physicians, Mesa, Arizona 85204
    • Reisha Zang 480-834-8804 reishazang@aol.com
    • Bruce Werber, DPM 480-834-8804 brw1150@usa.net

California

  • Foot and Ankle Institute of Santa Monica, Santa Monica California 90403
    • Nubia Diaz 310-828-0011 nubia@footankleinstitute.com
    • Babak Baravarian, DPM 310-828-0011

Florida

  • South Miami Foot Health Center, South Miami, Florida 33143
  • Keith Kashuk, DPM 305-667-5683 kbkashuk@gate.net
  • Georgia

    • Foot and Ankle Clinic of Oakwood, Oakwood, Georgia 30566
      • Cathy Rowan 770-536-7008 carfaco@charter.net
      • Thomas Brosky, II, DPM 770-535-1212 carfaco@charter.net
    • Ankle and Foot Specialist of Atlanta, Lithonia, Georgia, 30058
      • Arletha White 770-981-9011 awhite-45@hotmail.com

    Texas

    • Arlington Foot Center, Arlington, Texas 76014
      • Joe T. Southerland, DPM 817-467-1990 jtsouth@sbcglobal.net

    Virginia

    • Fredericksburg Foot & Ankle Center, Fredericksburg, Virginia 22408
      • Ross J. Girvan, DPM 540-374-5261 ross.girvan@verizon.net

    The third and final clinical trial is Conservative Treatment of Plantar Fasciitis With
    Dorsiflexion Night Splints and Medial Arch Supports
    . The purpose of this study is to compare the difference between the combined effect of both dorsiflexion night splints and medial arch supports in comparison the effect of splints and supports individually in the treatment of plantar fasciitis.

    Eligiblity for this test is participants over the age of 18 and is open to both male and female with plantar heel pain. Some of the conditions that will be excluded include gout, lupus, rheumatoid arthritis, ankylosing spondylitis, tarsal tunnel syndrome, or loss of plantar foot sensation.

    For more information about participation in this study you can contact:

    Pennsylvania

    • University of Pittsburgh, Pittsburgh, Pennsylvania 15260
      • Ahmad H Alghadir, MS, PT 412-726-1826 aha31@pitt.edu
      • James J Irrgang, PhD, PT 412-647-1237 irrgangjj@upmc.edu

    And for now…

    This concludes my plantar fasciitis discussion.

    References:
    U.S. National Library of Medicine
    National Institutes of Health
    USA.gov

    Advertisements

    One thought on “Clinical Trials for Plantar Fasciitis

    1. patsyhutch says:

      I’ve suffered from plantar fasciitis for more than 15 years. Its really an off an on thing. I’ve never been able to pin down exactly what causes it. I don’t know if there is something I’m doing. Like my walk or something that could be leading to it. When I do get it I find a night splint to be helpful.

    Leave a Reply

    Please log in using one of these methods to post your comment:

    WordPress.com Logo

    You are commenting using your WordPress.com account. Log Out / Change )

    Twitter picture

    You are commenting using your Twitter account. Log Out / Change )

    Facebook photo

    You are commenting using your Facebook account. Log Out / Change )

    Google+ photo

    You are commenting using your Google+ account. Log Out / Change )

    Connecting to %s